223 related articles for article (PubMed ID: 6717686)
1. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent splenocytes.
Dobaczewska H
Neoplasma; 1984; 31(2):165-8. PubMed ID: 6717686
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of in vivo antitumour activity of xenogeneic antiserum by autotransplanted normal spleen cells in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Rozmysłowicz T; Obłakowski P; Dobaczewska H
Eur J Cancer (1965); 1981 Jan; 17(1):77-80. PubMed ID: 7262149
[No Abstract] [Full Text] [Related]
3. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
Saha S; Mondal S
Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
Ghosh S; Maity P
Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
[TBL] [Abstract][Full Text] [Related]
5. In vivo suppression of Ehrlich ascites carcinoma by human antibody-dependent leukocytes.
Dobaczewska H
Neoplasma; 1982; 29(3):323-5. PubMed ID: 7133227
[No Abstract] [Full Text] [Related]
6. In vivo activity of spleen cells from untreated syngeneic mice against Ehrlich ascites carcinoma.
Jakóbisiak M; Kawiak J; Kawalec M; Kańtoch M; Kamiński M; Rozmysłowicz T
Folia Biol (Praha); 1979; 25(3):169-78. PubMed ID: 488466
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody.
Saha S; Mondal S
J Exp Clin Cancer Res; 2001 Mar; 20(1):75-84. PubMed ID: 11370834
[TBL] [Abstract][Full Text] [Related]
8. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
Senba T; Kuroki M; Arakawa F; Yamamoto T; Kuwahara M; Haruno M; Ikeda S; Matsuoka Y
Anticancer Res; 1998; 18(1A):17-24. PubMed ID: 9568050
[TBL] [Abstract][Full Text] [Related]
9. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect and mechanism of shikonin derivative SYUNZ-7].
Huang H; Xie BF; Zhu XF; Feng GK; Zhou JM; Wang Y; Wu HQ; Huang ZS; Gu LQ; Liu ZC
Ai Zheng; 2005 Dec; 24(12):1453-8. PubMed ID: 16351791
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent lysis of tumor cells in vivo. I. Early lysis of tumor cells.
Scornik JC; Klein PA
J Natl Cancer Inst; 1978 Oct; 61(4):1143-8. PubMed ID: 279715
[TBL] [Abstract][Full Text] [Related]
12. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
Mount PF; Sutton VR; Li W; Burgess J; McKEnzie IF; Pietersz GA; Trapani JA
Cancer Res; 1994 Dec; 54(23):6160-6. PubMed ID: 7954462
[TBL] [Abstract][Full Text] [Related]
13. Effect of weak combined static and extremely low-frequency alternating magnetic fields on tumor growth in mice inoculated with the Ehrlich ascites carcinoma.
Novikov VV; Novikov GV; Fesenko EE
Bioelectromagnetics; 2009 Jul; 30(5):343-51. PubMed ID: 19267367
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of the growth of Ehrlich transplantable carcinoma in mice by antichorionic immune serum].
Dil'man VM; Tsyrlina EV; Bulovskaia LN; Bobrov IuF
Vopr Onkol; 1983; 29(2):62-4. PubMed ID: 6836972
[TBL] [Abstract][Full Text] [Related]
15. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
Nersesyan A; Muradyan R; Arsenyan F
J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
[TBL] [Abstract][Full Text] [Related]
16. Antibody-dependent lysis of tumor cells in vivo. II. Elimination of chromium-51 as a measurement of cytolysis.
Scornik JC; Klein PA
J Natl Cancer Inst; 1978 Oct; 61(4):1149-54. PubMed ID: 212569
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
18. [Combined effect of an Ehrlich ascites tumor growth-inhibiting extract and adrenaline on cell division by that tumor in vitro].
Romanov IuA; Biks KA; Stepanova LI; Matsak NIa
Biull Eksp Biol Med; 1981 Feb; 91(2):202-4. PubMed ID: 7225558
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effect of Cantastim, an immunomodulatory agent extracted from a highly pathogenic Pseudomonas aeruginosa strain.
Olinescu A; Hristescu S; Sålågeanu A; Manda G; Neagu M
Neoplasma; 1991; 38(1):119-28. PubMed ID: 1901383
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
Gupta M; Mazumder UK; Kumar RS; Kumar TS
Acta Pharmacol Sin; 2004 Aug; 25(8):1070-6. PubMed ID: 15301742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
